NDC 75987-150

UPLIZNA

Inebilizumab

UPLIZNA is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Horizon Therapeutics Usa, Inc.. The primary component is Inebilizumab.

• Product ID: 75987-150_122316b3-8ee1-4a95-88bf-efa32505aab8
• NDC: 75987-150
• Product Type: Human Prescription Drug
• Proprietary Name: UPLIZNA
• Generic Name: Inebilizumab
• Dosage Form: Injection
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2020-06-11
• Marketing Category: BLA /
• Application Number: BLA761142
• Labeler Name: Horizon Therapeutics USA, Inc.
• Substance Name: INEBILIZUMAB
• Active Ingredient Strength: 10 mg/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 75987-150-03

3 VIAL, SINGLE-DOSE in 1 CARTON (75987-150-03) > 10 mL in 1 VIAL, SINGLE-DOSE (75987-150-01)

• Marketing Start Date: 2020-06-11
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "UPLIZNA" or generic name "Inebilizumab"

NDC	Brand Name	Generic Name
72677-551	UPLIZNA	Inebilizumab
75987-150	UPLIZNA	Inebilizumab